CAS 5085-72-3: (3R,4R,4aS,6aS,6bR,8aR,12aR,12bS,14aS,14bS)-4,4a,6b,8a,11,11,12b,14a-octamethyldocosahydropicen-3-ol

Friedelanol is a triterpenoid compound, which is isolated from various plant sources, prominently in the bark and leaves of certain tree species. Its chemical structure is characterized by multiple hydroxyl groups that critically influence its biological activity. The mode of action of Friedelanol involves the modulation of key signaling pathways, including anti-inflammatory and cytotoxic mechanisms. It interferes with specific enzymes and proteins that regulate cell proliferation and apoptosis, thereby exerting potential therapeutic effects. The uses and applications of Friedelanol primarily lie in its potential role as a bioactive agent in medical and pharmacological research. It is investigated for its efficacy in the treatment of various inflammatory disorders and its potential anti-cancer activities. The compound's ability to interact with cellular pathways makes it a subject of interest for developing new therapeutic strategies. Researchers are exploring its efficacy in vitro and in vivo to extend its applications in clinical settings. As such, Friedelanol remains a compound of significant interest for its diverse functional potential in scientific research.